Quarterly report pursuant to Section 13 or 15(d)

Net income per common share

v3.5.0.2
Net income per common share
6 Months Ended
Jul. 30, 2016
Earnings Per Share [Abstract]  
Net income per common share
7. Net income per common share

The following is a reconciliation of net income and the number of shares of common stock used in the computation of net income per basic and diluted share:

 

     13 Weeks Ended      26 Weeks Ended  
     July 30,      August 1,      July 30,      August 1,  

(In thousands, except per share data)

   2016      2015      2016      2015  

Numerator for diluted net income per share – net income

   $ 90,004       $ 74,169       $ 181,980       $ 141,115   

Denominator for basic net income per share – weighted-average common shares

     62,475         64,087         62,753         64,134   

Dilutive effect of stock options and non-vested stock

     338         323         314         350   
  

 

 

    

 

 

    

 

 

    

 

 

 

Denominator for diluted net income per share

     62,813         64,410         63,067         64,484   

Net income per common share:

           

Basic

   $ 1.44       $ 1.16       $ 2.90       $ 2.20   

Diluted

   $ 1.43       $ 1.15       $ 2.89       $ 2.19   

The denominators for diluted net income per common share for the 13 weeks ended July 30, 2016 and August 1, 2015 exclude 117 and 119 employee stock options and restricted stock units, respectively, due to their anti-dilutive effects. The denominators for diluted net income per common share for the 26 weeks ended July 30, 2016 and August 1, 2015 exclude 388 and 185 employee stock options and restricted stock, respectively, due to their anti-dilutive effects. As of July 30, 2016 and August 1, 2015, outstanding performance-based restricted stock units were excluded from the computation of diluted shares because the number of shares ultimately issued is contingent on the achievement of certain performance targets of the Company for which the performance targets have not yet been met.